Exclusive

Publication

Byline

Location

US Patent Issued to Samsung Display on July 7 for "Organometallic compound and organic light-emitting device including the same" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,966, issued on July 7, was assigned to Samsung Display Co. Ltd. (Yongin-si, South Korea). "Organometallic compound and organic light-emittin... Read More


US Patent Issued to Universal Display on July 7 for "Organic electroluminescent materials and devices" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,967, issued on July 7, was assigned to Universal Display Corp. (Ewing, N.J.). "Organic electroluminescent materials and devices" was invente... Read More


US Patent Issued to NUCLERA on July 7 for "Modified guanines" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,968, issued on July 7, was assigned to NUCLERA LTD (Cambridge, Great Britain). "Modified guanines" was invented by Gordon Ross McInroy (Camb... Read More


US Patent Issued to RISEN (SUZHOU) PHARMA TECH on July 7 for "CD73 inhibitors and pharmaceutical uses thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,969, issued on July 7, was assigned to RISEN (SUZHOU) PHARMA TECH Co. LTD. (Suzhou, China). "CD73 inhibitors and pharmaceutical uses thereof... Read More


US Patent Issued to Sage Therapeutics on July 7 for "Neuroactive steroids and their methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,970, issued on July 7, was assigned to Sage Therapeutics LLC (Rockville, Md.). "Neuroactive steroids and their methods of use" was invented ... Read More


US Patent Issued to O-FORCE on July 7 for "Amyloid-Beta aggregation inhibitor, pharmaceutical composition foramyloid-Beta aggregation disease, and use application of same" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,971, issued on July 7, was assigned to O-FORCE Co. LTD (Kochi, Japan). "Amyloid-Beta aggregation inhibitor, pharmaceutical composition foram... Read More


US Patent Issued to University of Pittsburgh-Of the Commonwealth System of Higher Education on July 7 for "Lung-specific targeting-peptide (LTP), compositions, and uses thereof" (Pennsylvania Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,972, issued on July 7, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh). "Lung-specific ... Read More


US Patent Issued to CAREGEN on July 7 for "Peptide having blood coagulation activity, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,973, issued on July 7, was assigned to CAREGEN CO LTD. (Anyang-si, South Korea). "Peptide having blood coagulation activity, and use thereof... Read More


US Patent Issued to Protagonist Therapeutics on July 7 for "Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases" (Australian, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,974, issued on July 7, was assigned to Protagonist Therapeutics Inc. (Newark, Calif.). "Oral peptide inhibitors of interleukin-23 receptor a... Read More


US Patent Issued to FUJIFILM on July 7 for "Cyclic peptide, cell scaffold material, cell separating material, and medium" (Japanese Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,975, issued on July 7, was assigned to FUJIFILM Corp. (Tokyo). "Cyclic peptide, cell scaffold material, cell separating material, and medium... Read More